Cerebral microvascular pathology in aging and Alzheimer's disease

Progress in Neurobiology

Volumn 64, Issue 6, 2001, Pages 575-611

  Farkas, Eszter ^a   Luiten, Paul G M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Aging; Alzheimer's disease; Capillary ultrastructure; Cerebral blood flow

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUCOSE; NITRIC OXIDE;

AGING; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BLOOD VESSEL OCCLUSION; BLOOD VESSEL WALL; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN MICROCIRCULATION; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; GLUCOSE BRAIN LEVEL; GLUCOSE UTILIZATION; HUMAN; LEARNING; METABOLIC RATE; NERVE CELL NETWORK; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0035047718     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00068-X     Document Type: Review

References (277)

1. Astrocyte-endothelial interaction: Physiology and pathology
2. Microvascular density of the human paraventricular nucleus decreases with aging but not hypertension
3. Influence of biological factors on changes in mean cerebral blood flow velocity in normal ageing: A transcranial Doppler study
4. Calcium channels in cerebral arteries
5. Age-related changes in brain microanatomy: Sensitivity to treatment with the dihydropyridine calcium channel blocker darodipine (PY 108-068)
6. Effect of long-term treatment with the dihydropyridine-type calcium channel blocker darodipine (PY 108-068) on the cerebral capillary network in aged rats
7. Endothelium-derived nitric oxide and vascular physiology and pathology
8. Astrocyte-mediated induction of tight junctions in brain capillary endothelium: An efficient in vitro model
9. Role of the CNS microvascular pericyte in the blood-brain barrier
10. Neurochemical stimulation of the rat substantia innominata increases cerebral blood flow (but not glucose use) through the parallel activation of cholinergic and non-cholinergic pathways
11. The double-edged role of nitric oxide in brain function and superoxide-mediated injury
12. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment
13. Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion
14. Agrin and microvascular damage in Alzheimer's disease
15. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats
16. Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients
17. Molecular regulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors
18. The physiology of the cerebrovascular parasympathetic innervation
19. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study
20. Brain microvascular changes in Alzheimer's disease and other dementias
21. Mechanisms of cerebrovascular amyloid deposition. Lessons from mouse models
22. Cablin: A novel protein of the capillary basal lamina
23. Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients
24. Serotonin in the regulation of brain microcirculation
25. Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex
26. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: Molecular and pharmacologic characterization
27. Cerebral amyloid angiopathies
28. CBF tomograms with [99mTc]-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - Initial results
29. Development of collaterals in the cerebral circulation
30. Microvascular changes in aged rat forebrain. Effects of chronic nimodipine treatment
31. Nimodipine effects on cerebral microvessels and sciatic nerve in aging rats
32. Formation of cerebrovascular anomalies in the ageing rat is delayed by chronic nimodipine application
33. Cerebrovascular hypoperfusion: A risk factor for Alzheimer's disease? Animal model and postmortem human studies
34. Cerebral hypoperfusion yields capillary damage in hippocampus CA1 that correlated to spatial memory impairment
35. Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
36. Can disturbed brain microcirculation cause Alzheimer's disease?
37. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats
38. Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats
39. Assessing utility of single photon emission computed tomography (SPECT) scan in Alzheimer disease: Correlation with cognitive severity
40. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization
41. Computer modeling of cerebral blood flow following internal carotid artery occlusion
42. Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus
43. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: Regulation by cyclic nucleotides
44. Reduced temporal lobe blood flow in Alzheimer's disease
45. Reduced temporal lobe glucose metabolism in aging
46. Peptidergic innervation of the cerebral circulation. Role in subarachnoid hemorrhage in man
47. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: Identification and cellular localization
48. Cerebral microvascular breakdown in Alzheimer's disease and in experimental cerebral hypoperfusion
49. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link?
50. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?
51. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease
52. Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain
53. Mechanisms of action of calcium antagonists in heart and vascular smooth muscle
54. Signal transduction of eNOS activation
55. Alzheimer's disease: Anterior-posterior and lateral hemispheric alterations in cortical glucose utilization
56. Regional cerebral glucose transport and utilization in Alzheimer's disease
57. Cerebral blood flow and brain function in hypertension
58. Alzheimer's disease and heparan sulfate proteoglycan
59. Altered cerebral energy metabolism in Alzheimer's disease: A PET study
60. Cholinergic fiber aberrations in nucleus basalis lesioned rat and Alzheimer's disease
61. Double-tracer study of the fine regional blood-brain barrier glucose transfer in the rat by computer-assisted autoradiography
62. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells
63. Endothelial cell-astrocyte interactions. A cellular model of the blood-brain barrier
64. Effects of lesioning of the substantia innominata on autoregulation of local cerebral blood flow in rats
65. Identification of muscarinic receptors in rat cerebral cortical microvessels
66. Effects of aging on cerebral vascular responses to serotonin in rats
67. Influence of transmural pressure of myogenic responses of isolated cerebral arteries of the rat
68. A cellular mechanism for myogenic regulation of cat cerebral arteries
69. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue
70. Influence of haematocrit in the cerebral circulation
71. Effect of haematocrit on carotid stenosis and cerebral infarction
72. Circle of Willis collateral flow investigated by magnetic resonance angiography
73. Morphological changes of blood vessels in the brain with Alzheimer's disease
74. Age-related changes in rat brain capillaries
75. Ultrastructural changes of blood vessels in the cerebral cortex in Alzheimer's disease
76. Electron microscopy of the blood-brain barrier in disease
77. Pericytes in the microvasculature
78. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
79. Linear coupling between cerebral blood flow and oxygen consumption in activated human cortex
80. Scopolamine reduces frontal cortex perfusion
81. Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease
82. The effect of age on glucose and energy metabolism in brain cortex of rats
83. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: A cross-sectional comparison against advanced late-onset and incipient early-onset cases
84. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
85. Blood flow in the cerebral capillary network: A review emphasizing observation with intravital microscopy
86. Effect of hemodilution on RBC velocity, supply rate, and hematocrit in the cerebral capillary network
87. Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells
88. The influence of oxygen free radicals on the permeability of the monolayer of cultured brain endothelial cells
89. Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: Correlation between neuropsychiatric evaluation and CBF images
90. Basement membranes, microfibrils and beta amyloid fibrillogenesis in Alzheimer's disease: High resolution ultrastructural findings
91. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography
92. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease
93. Regional cerebral blood flow changes in aging
94. Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats
95. Single-dose kinetics of nifedipine in rat plasma and brain
96. Adenosine-induced release of nitric oxide from cortical astrocytes
97. The blood-brain barrier: Cellular basis
98. Astrocytes secrete a factor inducing the expression of HT7-protein and neurothelin in endothelial cells of chorioallantoic vessels
99. Age related alterations in the response of the pial arterioles to adenosine in the rat
100. 2 content on cerebral blood flow in the lamb
101. Laminins in the adult and aged brain
102. Review: Does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI
103. Cerebral vessels in aging and Alzheimer's disease
104. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease
105. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease
106. Differential degeneration of the cerebral microvasculature in Alzheimer's disease
107. Increased collagen content of cerebral microvessels in Alzheimer's disease
108. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease
109. Decreased local cerebral blood flow in young and aged spontaneously hypertensive rats
110. Cellular actions and pharmacology of calcium-channel blockers
111. Leuko-araiosis and cerebral perfusion in normal aging
112. Rheology of the cerebral circulation
113. Microvascular pericyte contractility in vitro: Comparison with other cells of the vascular wall
114. Testing neural network models of memory with behavioral experiments
115. Capillary changes in hippocampal CA1 and CA3 areas of the aging rhesus monkey
116. Observations of microvessels in the brain with Alzheimer's disease by scanning electron microscopy
117. Inter-dependency of local capillary density, blood-flow and metabolism in rat brains
118. Tight junctions of the blood-brain barrier
119. Distinguishing patients with senile dementia of Alzheimer type and normal elderly subjects utilizing xenon CT-CBF and multivariate analysis
120. Assessment of demented patients by dynamic SPECT of inhaled xenon-133
121. Transcranial color Doppler sonography of basal cerebral arteries in 182 healthy subjects: Age and sex variability and normal reference values for blood flow parameters
122. The effect of normal aging on patterns of local cerebral glucose utilization
123. High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease
124. Physiology of cerebral blood flow and metabolism
125. Reduced cortical vasodilatory response to stimulation of the nucleus basalis of Meynert in the aged rat and evidence for a control of the cerebral circulation
126. Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier
127. Dihydropiridine calcium antagonist in mice: Blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures
128. Morphology of cerebral arteries
129. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age
130. Hemodilution accelerates the passage of plasma (not red cells) through cerebral microvessels in rats
131. Innervation of cerebral arteries by nerves containing 5-hydroxytryptamine and noradrenaline
132. Cortical cerebral blood flow governed by the basal forebrain: Age-related impairments
133. Oxidative stress in brain ischemia
134. Distribution of nicotinamide adenine dinucleotide phosphate (NADPH)-dependent diaphorase staining in intraparenchymal blood vessels of the rat brain
135. Effects of excitatory amino acids on cerebral oxygen consumption and blood flow in rat
136. 2+ channel blockade in aging normotensive and hypertensive rat strains
137. Ultrastructural localization of cholinergic muscarinic receptors in rat brain cortical capillaries
138. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy
139. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease
140. Endothelial mitochondrial content of cerebral cortical capillaries in Alzheimer's disease. An ultrastructural quantitative study
141. Regional cerebral oxygen consumption, blood flow, and blood volume in healthy human aging
142. Retinal pericytes control expression of nitric oxide synthase and endothelin-1 in microvascular endothelial cells
143. The role of endothelin-1 in pressure autoregulation of cerebral blood flow in rats
144. Principles of Doppler signal processing and hemodynamic analysis
145. Brain vasculature and mitochondrial responses to ischemia in gerbils. I. Basic anatomical patterns and biochemical correlates
146. The distribution of blood to the brain
147. Microcirculatory stasis induced by hemorheological disorders: Further evidence
148. Stereologic findings in normal brain aging and Alzheimer's disease
149. New models of focal cerebral ischaemia
150. Substance P-immunoreactive astrocytes related to deep white matter and striatal blood vessels in human brain
151. In vitro interaction of astrocytes and pericytes with capillary-like structures of brain microvessel endothelium
152. Chemodenervation does not alter cerebrovascular response to hypoxic hypoxia
153. Morphological changes of microvessels in the brain with Alzheimer's disease
154. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease
155. Effect of aging on the blood-brain barrier
156. Glucose transport is reduced in the blood-brain barrier of aged rats
157. GLUT-1 expression in the cerebra of patients with Alzheimer's disease
158. Excitotoxic lesions of basal forebrain cholinergic neurons: Effects on learning, memory and attention
159. Pathophysiology and treatment of cerebral ischemia
160. Cerebral blood flow and metabolism in hypertensive patients with cerebral infarction
161. Effect of TAK-147, a novel AChE inhibitor, on cerebral energy metabolism
162. Chronic cerebral hypoperfusion-induced neuropathological changes in rats
163. Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls
164. Ultrastructural evidence of early non-fibrillar Abeta42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type
165. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats
166. Regional cerebral blood flow in chronic hypertension. A correlative study
167. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease
168. High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases
169. Chronic cerebral hypoperfusion by permanent internal carotid ligation produces learning impairment without brain damage in rats
170. Acute effects of antihypertensive agents on cerebral blood flow in hypertensive rats
171. Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase
172. Cerebral amyloid angiopathy. A review
173. Chronic reduction of cerebral blood flow in the adult rat: Late-emerging CA1 cell loss and memory dysfunction
174. Chronic ischemia: Memory impairment and neural pathology in the rat
175. Does the brain's gatekeeper falter in aging?
176. Aβ vasoactivity: An inflammatory reaction
177. Cerebral autoregulation
178. Quantitative and ultrastructural changes in glia and pericytes in the parietal cortex of the aging rat
179. Microvascular pathology and vascular basement membrane components in Alzheimer's disease
180. Microangiopathy, the vascular basement membrane and Alzheimer's Disease
181. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease
182. Association between vascular basement membrane components and the lesions of Alzheimer's disease
183. Tacrine overcompensates for the decreased blood flow induced by basal forebrain lesion in the rat
184. Differentiated cerebrovascular effects of physostigmine and tacrine in cortical areas deafferented from the nucleus basalis magnocellularis suggest involvement of basalocortical projections to microvessels
185. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping
186. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide
187. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier
188. beta-amyloid induces cerebrovascular endothelial dysfunction in the rat brain
189. Development of an in vitro cell culture system to mimic the blood-brain barrier
190. Cerebral cortical and white matter reactivity to carbon dioxide
191. Mechanoreception by the endothelium: Mediators and mechanisms of pressure- and flow-induced vascular responses
192. The cell biology of the blood-brain barrier
193. Cellular mechanisms of CNS pericytes
194. Disruption of blood-brain barrier following bilateral carotid artery occlusion in spontaneously hypertensive rats. A quantitative study
195. Age related changes in blood-to-brain amino acid transport and incorporation into brain protein
196. Local cerebral blood flow responses in rats to hypercapnia and hypoxia in the rostral ventrolateral medulla and in the cortex
197. Barriers in the immature brain
198. Alterations of the cerebral capillary bed in the senile dementia of Alzheimer
199. Alzheimer's disease as a capillary dementia
200. Macrorheology and microrheology of blood in cerebrovascular insufficiency
201. 2+ regulation
202. Age-related changes in regional cerebral blood flow among young to mid-life adults
203. Calcium antagonists in aging brain
204. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats
205. Pharmacological basis for the use of nimodipine in central nervous system disorders
206. Age-related changes in the blood-brain barrier
207. Hippocampus as a memory map: Synaptic plasticity and memory encoding by hippocampal neurons
208. Pericyte physiology
209. The amyloid beta-protein precursor is localized in smooth muscle cells of leptomeningeal vessels
210. Glutamate, calcium, and free radicals as mediators of ischemic brain damage
211. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
212. The relationship between blood pressure and dementia: A review
213. A 15-year longitudinal study on blood pressure and dementia
214. An experimental model of carotid artery occlusive disease
215. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease
216. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1
217. A quantitative analysis of blood-brain barrier ultrastructure in the aging human
218. A morphometric study of the blood-brain barrier in Alzheimer's disease
219. Blood pressure control in eNOS knock-out mice: Comparison with other species under NO blockade
220. In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability
221. Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity
222. The cerebrovascular parasympathetic innervation
223. Changing topographic patterns of human cerebral blood flow with age measured by xenon CT
224. Local cerebral glucose utilization in the hippocampus of old rats
225. Ultrastructural changes in cerebral pericytes and astrocytes of stroke-prone spontaneously hypertensive rats
226. Age-related decline of cerebral oxygen metabolism in normal population detected with positron emission tomography
227. Effect of an antihypertensive drug, budralazine, on the cerebral circulation in spontaneously hypertensive rats
228. Effect of haematocrit on cerebral blood-flow in man
229. In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid
230. Brain macrophages: On the role of pericytes and perivascular cells
231. Effect of the calcium antagonist felodipine and nimodipine on cortical blood flow in the spontaneously hypertensive rat
232. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease
233. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats
234. Local cerebral glucose utilisation following acute and chronic bilateral carotid artery ligation in Wistar rats: Relation to changes in local cerebral blood flow
235. Effects of recombinant eNOS gene expression on reactivity of small cerebral arteries
236. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists
237. Neuropeptides in the cerebral circulation
238. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: Implications for cerebral amyloid angiopathy
239. Mechanisms of cerebral blood flow regulation
240. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: A review of immunocytochemical localization in relation to learning and memory
241. Changes in PKC gamma immunoreactivity in mouse hippocampus induced by spatial discrimination learning
242. Glucose transporter expression in brain: Relationship to cerebral glucose utilization
243. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: Electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry
244. Autoradiographic study of the cerebrovascular effects of stimulation of the substantia innominata: Convenient stimulation paradigm
245. Autoradiographic distribution of cerebral blood flow increases elicited by stimulation of the nucleus basalis magnocellularis in the unanesthetized rat
246. Autoradiographic evidence for flow-metabolism uncoupling during stimulation of the nucleus basalis of Meynert in the conscious rat
247. Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex
248. Rapid degeneration of cultured human brain pericytes by amyloid beta protein
249. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain
250. Cerebral amyloid angiopathy. A critical review
251. Transcranial pulsed Doppler measurements of blood velocity in the middle cerebral artery: Reference values at rest and during hyperventilation in healthy volunteers in relation to age and sex
252. Cerebrovascular transmural pressure and autoregulation
253. Local chemical, neural, and humoral regulation of cerebrovascular resistance vessels
254. Regulation of cerebral blood flow - A brief review
255. Heterogenity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: A [99mTc]-d,l-HMPAO SPECT study
256. Pressure-induced myogenic responses in human isolated cerebral resistance arteries
257. 2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins
258. Chemiluminescence detection of nitric oxide production from rat cerebral cortical endothelial cells in culture
259. Models of hypoxia and cerebral ischemia
260. Effects of nimodipine and verapamil on cerebral blood flow and cerebrovascular reactivity in conscious rabbits
261. The cholinergic deficit in Alzheimer's disease
262. Endothelial nitric oxide synthetase (eNOS) in astrocytes: Another source of nitric oxide in neocortex
263. In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels
264. Role of perivascular cells and myocytes in vascular amyloidosis
265. Local cerebral glucose utilization in the brain of old, learning impaired rats
266. Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
267. Reduction in regional cerebral metabolic rate of oxygen during human aging
268. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study
269. Vascular changes in the brains with Alzheimer's disease
270. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells
271. Vascular basement membrane pathology and Alzheimer's disease
272. Nimodipine inhibits calcium-independent nitric oxide synthase activity in transient focal cerebral ischemia rats and cultured mouse astroglial cells
273. Endothelin and subarachnoid hemorrhage: An overview
274. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier
275. Mechanism of endothelin-1-induced contraction in rabbit basilary artery